Related Experiment Video
Updated: May 25, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Neuroprotective properties of nicotine
1University of Hohenheim, Institute of Physiology, Stuttgart, Germany. michaela.sieber@uni-hohenheim.de
Nicotine protects retinal cells from excitotoxic damage by activating glutamate receptors. This neuroprotection involves decreased retinal spreading depression (rSD) wave velocity, suggesting a novel therapeutic pathway.
Area of Science:
- Neuroscience
- Ophthalmology
- Pharmacology
Background:
- Excitotoxic cell death is a significant cause of neuronal damage.
- Retinal spreading depression (rSD) waves reflect tissue activity and vulnerability.
- Nicotine's effects on neuronal function are mediated through nicotinic acetylcholine receptors (nAChRs).
Purpose of the Study:
- To investigate the neuroprotective effects of nicotine against NMDA-induced excitotoxicity in retinal tissue.
- To examine the impact of nicotine on rSD wave propagation velocity.
- To elucidate the role of glutamate receptors in nicotine's protective mechanism.
Main Methods:
- Utilized in vivo near tissue preparation of retinal tissue.
- Measured intrinsic optical signal (IOS) changes during rSD waves.
- Induced excitotoxicity using NMDA (N-methyl-D-aspartate) and assessed protective effects of nicotine and epibatidine.
Main Results:
- Nicotine demonstrated significant neuroprotective effects against NMDA-induced excitotoxicity.
- Nicotine application decreased the propagation velocity of rSD waves.
- Epibatidine, a specific nAChR agonist, mimicked nicotine's protective effects.
Conclusions:
- Nicotine exerts neuroprotective effects in the retina against excitotoxic insults, mediated by glutamate receptor activation.
- Nicotine's modulation of rSD wave velocity suggests a role in regulating neuronal excitability.
- These findings highlight the potential of nAChR agonists as therapeutic agents for retinal neuroprotection.
More Related Videos
12:19Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Neurochemical Transmission: Sites of Drug Action
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Affecting Neurotransmitter Release or Uptake